142 related articles for article (PubMed ID: 24980853)
41. Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH.
Sunohara K; Mitsuhashi S; Shigetomi K; Ubukata M
Bioorg Med Chem Lett; 2013 Sep; 23(18):5140-4. PubMed ID: 23937979
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of IMPDH by mycophenolic acid: dissection of forward and reverse pathways using capillary electrophoresis.
Fleming MA; Chambers SP; Connelly PR; Nimmesgern E; Fox T; Bruzzese FJ; Hoe ST; Fulghum JR; Livingston DJ; Stuver CM; Sintchak MD; Wilson KP; Thomson JA
Biochemistry; 1996 Jun; 35(22):6990-7. PubMed ID: 8679523
[TBL] [Abstract][Full Text] [Related]
43. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
Wright DG; Boosalis M; Malek K; Waraska K
Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
[TBL] [Abstract][Full Text] [Related]
44. Allosteric properties of inosine monophosphate dehydrogenase revealed through the thermodynamics of binding of inosine 5'-monophosphate and mycophenolic acid. Temperature dependent heat capacity of binding as a signature of ligand-coupled conformational equilibria.
Bruzzese FJ; Connelly PR
Biochemistry; 1997 Aug; 36(34):10428-38. PubMed ID: 9265623
[TBL] [Abstract][Full Text] [Related]
45. Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase.
Zhang R; Evans G; Rotella FJ; Westbrook EM; Beno D; Huberman E; Joachimiak A; Collart FR
Biochemistry; 1999 Apr; 38(15):4691-700. PubMed ID: 10200156
[TBL] [Abstract][Full Text] [Related]
46. Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.
Rejman D; Olesiak M; Chen L; Patterson SE; Wilson D; Jayaram HN; Hedstrom L; Pankiewicz KW
J Med Chem; 2006 Aug; 49(16):5018-22. PubMed ID: 16884314
[TBL] [Abstract][Full Text] [Related]
47. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
[TBL] [Abstract][Full Text] [Related]
48. Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods/rings that are primarily stationary and stable structures.
Keppeke GD; Andrade LE; Grieshaber SS; Chan EK
Cell Biosci; 2015; 5(1):1. PubMed ID: 25601894
[TBL] [Abstract][Full Text] [Related]
49. Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.
Chen L; Petrelli R; Olesiak M; Wilson DJ; Labello NP; Pankiewicz KW
Bioorg Med Chem; 2008 Aug; 16(15):7462-9. PubMed ID: 18583139
[TBL] [Abstract][Full Text] [Related]
50. Interfilament interaction between IMPDH and CTPS cytoophidia.
Chang CC; Keppeke GD; Sung LY; Liu JL
FEBS J; 2018 Oct; 285(20):3753-3768. PubMed ID: 30085408
[TBL] [Abstract][Full Text] [Related]
51. Regulation of IL2 and NUCB1 in mononuclear cells treated with acyl glucuronide of mycophenolic acid reveals effects independent of inosine monophosphate dehydrogenase inhibition.
Petrova DT; Heller T; Hitt R; Wieland E; Oellerich M; Armstrong VW; Shipkova M
Ther Drug Monit; 2009 Feb; 31(1):31-41. PubMed ID: 19065122
[TBL] [Abstract][Full Text] [Related]
52. IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex.
Pua KH; Stiles DT; Sowa ME; Verdine GL
Cell Rep; 2017 Jan; 18(2):432-442. PubMed ID: 28076787
[TBL] [Abstract][Full Text] [Related]
53. Inhibitory effect of curcumin on IMP dehydrogenase, the target for anticancer and antiviral chemotherapy agents.
Dairaku I; Han Y; Yanaka N; Kato N
Biosci Biotechnol Biochem; 2010; 74(1):185-7. PubMed ID: 20057137
[TBL] [Abstract][Full Text] [Related]
54. Monovalent cation activation in Escherichia coli inosine 5'-monophosphate dehydrogenase.
Kerr KM; Cahoon M; Bosco DA; Hedstrom L
Arch Biochem Biophys; 2000 Mar; 375(1):131-7. PubMed ID: 10683258
[TBL] [Abstract][Full Text] [Related]
55. IMPDH forms the cytoophidium in zebrafish.
Keppeke GD; Chang CC; Antos CL; Peng M; Sung LY; Andrade LEC; Liu JL
Dev Biol; 2021 Oct; 478():89-101. PubMed ID: 34048735
[TBL] [Abstract][Full Text] [Related]
56. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade.
Petrelli R; Vita P; Torquati I; Felczak K; Wilson DJ; Franchetti P; Cappellacci L
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):103-25. PubMed ID: 23016672
[TBL] [Abstract][Full Text] [Related]
57. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
Yu J; Lemas V; Page T; Connor JD; Yu AL
Cancer Res; 1989 Oct; 49(20):5555-60. PubMed ID: 2571408
[TBL] [Abstract][Full Text] [Related]
58. Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors.
Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Jayaprakasan V; Jayaram HN; Boyd DB; Jain MD; Grifantini M
Bioorg Med Chem; 2005 Mar; 13(6):2045-53. PubMed ID: 15727858
[TBL] [Abstract][Full Text] [Related]
59. Induction of cytoplasmic pattern in the form of "rods and rings" through the treatment of hepatitis C: a case report.
Felisberto M; Jorge AS; Menolli RA; Gnutzmann LV; Nesi V
Rev Bras Reumatol; 2015; 55(2):181-4. PubMed ID: 25476473
[TBL] [Abstract][Full Text] [Related]
60. SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling.
Li TW; Kenney AD; Park JG; Fiches GN; Liu H; Zhou D; Biswas A; Zhao W; Que J; Santoso N; Martinez-Sobrido L; Yount JS; Zhu J
Front Immunol; 2022; 13():1007089. PubMed ID: 36177032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
